According to the
Global Burden of Disease Study, 2017, about 16% of disability cases were a
result of musculoskeletal conditions, which is the second-largest cause of
global disability. These conditions comprise more than 150 diagnoses that
affect the bones, muscles, joints, and associated tissues — collectively
referred to as the locomotor system. The most common and disabling musculoskeletal
conditions are osteoarthritis and systemic inflammatory conditions, such as
rheumatoid arthritis (RA). The prevalence of RA lies between 0.3 and 1%, and
the condition more commonly affects females. Further, globally, symptomatic
osteoarthritis affects 9.6% men and 18% women over 60 years of age.
Moreover, with
aging, numerous changes occur in the cartilage and connective tissue. The joints
become less resilient and more susceptible to damage due to the thinning of the
cartilage and altering of its components (proteoglycans — supportive structures
of the cartilage). This may either lead to osteoarthritis or stiffness in the
joints; therefore, elderly people are more susceptible to such conditions as
compared to young people. Many European countries, such as Italy, Germany,
France, and Spain, are witnessing an increase in the geriatric population. This
is resulting in the growing demand for diagnostic techniques and treatments for
bone-related disorders. This factor, along with the rising prevalence of
musculoskeletal diseases, is contributing to the increasing requirement for
small joint reconstructive implants.
Browse report overview and detailed TOC on Small Joint Reconstructive Implants Market Growth
The highest
usage of small
joint reconstructive implants was observed in the North American region, among all other regions, such
as Middle East & Africa, Europe, Latin America, Europe, and Asia-Pacific
(APAC), in the past. This was attributed to the well-established healthcare
industry in the region, technological advancements, and high adoption rate of
such implants. In the coming time, the fastest growth in demand for small joint
reconstructive implants will be registered by the APAC region.
This can be
ascribed to the sedentary lifestyle of people and growing incidents of road
accidents. The World Health Organization reported that in China, road traffic
injuries are the major cause of death of people in the 15–44 age group.
Further, India is also witnessing a surge in road accidents, which is adding to
the demand for joint implants in the region.
